China NMPA Drug Inspection - Xuzhou Longrun Pharmaceutical Packaging Co., Ltd. - Polyester/low-density polyethylene composite film for pharmaceutical packaging (batch number 17040103)
China NMPA drug inspection for Xuzhou Longrun Pharmaceutical Packaging Co., Ltd. published December 08, 2017. Drug: Polyester/low-density polyethylene composite film for pharmaceutical packaging (batch number 17040103). The State Administration for Market Regulation issued Announcement No. 200 of 2017 on December 8, 2017, detailing findin
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Xuzhou Longrun Pharmaceutical Packaging Co., Ltd. published December 08, 2017. Drug: Polyester/low-density polyethylene composite film for pharmaceutical packaging (batch number 17040103). The State Administration for Market Regulation issued Announcement No. 200 of 2017 on December 8, 2017, detailing findin
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox